Back

ATR-I774Yfs*5 promotes genomic instability through micronuclei formation

D'Orazio, J.; Holcomb, N.; Pu, H.; Dhar, B.; Bautista, R.; Overmann, A.; Shelton, B.; Corum, L.

2022-03-12 cancer biology
10.1101/2022.03.10.483800 bioRxiv
Show abstract

Although mismatch repair (MMR) defects are associated with high risk of malignancy, the specific oncogenic drivers pertinent to MMR-affected cancers are poorly characterized. The heterozygous ATR-I774Yfs*5 mutation, the result of strand slippage in a poly-A tract of the Ataxia Telangiectasia and Rad3 related (ATR) gene, is overexpressed in MMR-defective malignancies including colorectal carcinoma (CRC) and is the most common ATR mutation in cancer. Here, we explore the contribution of ATR-I774Yfs*5 to genomic integrity. Using heterozygous ATR-I774Yfs*5 HCT-116 cells to mimic the native mutation, we found this mutation reduced ATR activity as measured by damage-induced Chk1 phosphorylation at S317 and ATR autophosphorylation ATR at T1989. ATR-I774Yfs*5 expression impaired genomic stability as visualized by the appearance of micronuclei in two stable expression models as well as in cell lines transfected with ATR-I774Yfs*5. Micronucleus development was dependent on replication and independent of ATR copy number. ATR-I774Yfs*5 expression did not alter cellular viability, cell cycle progression, or replicative rate, suggesting this mutation is well-tolerated despite its destabilizing effect on the genome. Taken together, these data suggest that the ATR-I774Yfs*5, whose development is favored in the context of MMR deficiency, may represent an important driver of a mutator phenotype by promoting genomic instability.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Cancers
200 papers in training set
Top 0.2%
14.3%
2
Scientific Reports
3102 papers in training set
Top 4%
12.3%
3
DNA Repair
17 papers in training set
Top 0.1%
4.8%
4
Clinical Epigenetics
53 papers in training set
Top 0.2%
3.9%
5
Molecular Oncology
50 papers in training set
Top 0.1%
3.6%
6
Nucleic Acids Research
1128 papers in training set
Top 6%
3.6%
7
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.6%
8
Oncotarget
15 papers in training set
Top 0.1%
2.1%
9
Molecular and Cellular Biology
40 papers in training set
Top 0.1%
1.9%
10
NAR Cancer
36 papers in training set
Top 0.1%
1.9%
50% of probability mass above
11
PLOS ONE
4510 papers in training set
Top 54%
1.7%
12
Molecular Cancer Research
42 papers in training set
Top 0.3%
1.7%
13
Oncogene
76 papers in training set
Top 1%
1.7%
14
Cancer Research
116 papers in training set
Top 2%
1.5%
15
BMC Cancer
52 papers in training set
Top 2%
1.5%
16
Cells
232 papers in training set
Top 3%
1.3%
17
PLOS Genetics
756 papers in training set
Top 10%
1.3%
18
Cell Death & Disease
126 papers in training set
Top 2%
1.2%
19
npj Genomic Medicine
33 papers in training set
Top 0.6%
1.2%
20
Nature Communications
4913 papers in training set
Top 56%
1.2%
21
Frontiers in Genetics
197 papers in training set
Top 7%
1.2%
22
Communications Biology
886 papers in training set
Top 16%
1.1%
23
Neurobiology of Disease
134 papers in training set
Top 3%
0.9%
24
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
0.9%
25
Cell Cycle
14 papers in training set
Top 0.3%
0.9%
26
Frontiers in Molecular Biosciences
100 papers in training set
Top 4%
0.9%
27
Blood
67 papers in training set
Top 1%
0.8%
28
Neoplasia
22 papers in training set
Top 0.6%
0.8%
29
Cell Reports
1338 papers in training set
Top 32%
0.8%
30
Genes
126 papers in training set
Top 3%
0.8%